Transcutaneous Oxygen Pressure Measurements with an Electrode Core Temperature of 37 °C

  • A. Creutzig
  • D. Dau
  • K. Alexander
Conference paper


The oxygen pressure of the healthy skin fluctuates between 0 and 4 mm Hg [5]. The application of hyperemizating ointment or heat causes skin oxygen pressure to rise; maximum hyperemia results at temperatures above 40 °C, while the blood flow remains constant [8]. A further increase in blood flow, such as one induced by drugs, cannot be expected, just as a reactive hyperemia cannot be measured. In earlier investigations, a uniform decline in tcPO2 was observed when an electrode was used at 44 °C in patients with arterial occlusive disease under an intra-arterial infusion of various drugs. This we interpreted as a steal phenomenon [2]. If, however, electrode core temperatures between 37 °C and 39 °C are selected, changes in the cutaneous blood flow can be detected [6]. In the following, the results of tcPO2 investigations using an electrode core temperature of 37 °C are reported.


Nicotinate Adenosine Prostaglandin Dextran Nucleoside 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bollinger, A., E.Lüthy: Kompensationsgrad arterieller Verschlüsse und Wirkung intravenös verabreichter vasoaktiver Medikamente. Schweiz, med. Wschr. 97 (1967) 1220–1225Google Scholar
  2. 2.
    Creutzig, A., K. Alexander: Die Bestimmung des transkutanen Sauerstoffdruckes der durchblutungsgestörten Extremität bei konservativer Therapie der AVK. Dt. Ges. Inn. Med. 89 (1983) 536–540Google Scholar
  3. 3.
    Creutzig, A., D. Dau, K. Alexander: Transkutaner Sauerstoffdruck während intraarterieller Infusionen. VASA 13 (1984) 207–212PubMedGoogle Scholar
  4. 4.
    Creutzig, A., M.Lux, K. Alexander: Muscle tissue oxygen pressure fields and transcutaneous oxygen pressure in healthy men during intra-arterial Prostaglandin E1 infusion. Intern. Angiol. 3 (1984)105–110Google Scholar
  5. 5.
    Evans, N.T.S., P. F. D. Naylor: The systemic oxygen supply to the surface of human skin. Resp. Physiol. 3 (1967) 21–37CrossRefGoogle Scholar
  6. 6.
    Ewald, U., G. Rooth, T.Tuvemo: Postischemic hyperaemia studied with a transcutaneous oxygen electrode used at 33–37 °C. Scand. J. Clin. Lab. Invest. 41 (1981) 641–645PubMedCrossRefGoogle Scholar
  7. 7.
    Gottstein, U., R. Felix, H.D.Flad, I.Sedlmayr: Untersuchungen zur Wirkung von Nikotinsäure und Adenosinmonophosphat auf Haut- und Muskeldurchblutung von Gefäßgesunden und Kranken mit peripheren Durchblutungsstörungen. Z. Kreisl. Forsch. 55 (1966) 970–987Google Scholar
  8. 8.
    Huch, R., A. Huch, D.W.Lübbers: Transcutaneous pO2. Thieme-Verlag, Stuttgart (1981)Google Scholar
  9. 9.
    Nielsen, P.E., S.L.Nielsen, P.Holstein, H.L.Poulsen, E.H.Hansen, N.A.Lassen: Intraarterial infusion of Prostaglandin E1 in normal subjects and patients with peripheral arterial disease. Scand. J. Clin. Lab. Invest. 36 (1976) 633–640PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • A. Creutzig
  • D. Dau
  • K. Alexander

There are no affiliations available

Personalised recommendations